The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research ...

Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

Georgia has moved to renew contracts with Israeli technology firm Cellebrite DI Ltd for software used to extract data from ...

Cellebrite DI Ltd. (CLBT) has been on a downward spiral lately with significant selling pressure. After declining 17.6% over the past four weeks, the stock looks well positioned for a trend ...

CLBT's ambitious financial targets include 24% CAGR in ARR and 20% CAGR in total revenues by 2028, with significant margin improvements since 2022. Despite a potential short-term sell-off ...

Cellebrite DI Ltd.’s CLBT share price has dipped by 12.92%, which has investors questioning if this is right time to buy.

Meeting to be held in Toronto, Canada on March 4 hosted by Needham.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Meeting to be held in Chicago on March 5 and in Denver on March 6 hosted by Craig-Hallum. Discover the Best Stocks and Maximize Your Portfolio: ...